Los Angeles Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98K Sell
257
-2,106
-89% -$15.4K ﹤0.01% 2289
2025
Q4
$22.8K Buy
+2,363
New +$25.5K ﹤0.01% 1833
2025
Q1
Sell
-23,808
Closed -$404K 1087
2024
Q4
$404K Buy
23,808
+375
+2% +$7.06K ﹤0.01% 861
2024
Q3
$544K Buy
+23,433
New +$501K ﹤0.01% 842
2023
Q3
Sell
-10,572
Closed -$303K 1115
2023
Q2
$303K Sell
10,572
-1,750
-14% -$47.6K ﹤0.01% 1000
2023
Q1
$295K Hold
12,322
﹤0.01% 1011
2022
Q4
$209K Hold
12,322
﹤0.01% 1135
2022
Q3
$183K Hold
12,322
﹤0.01% 1177
2022
Q2
$194K Sell
12,322
-47,308
-79% -$928K ﹤0.01% 1272
2022
Q1
$1.61M Buy
+59,630
New +$1.52M 0.01% 597
2021
Q3
Sell
-8,357
Closed -$283K 1469
2021
Q2
$283K Buy
+8,357
New +$283K ﹤0.01% 1410

Other funds holding ARCT